REDOXTHERAPIES

RedoxTherapies is a privately held company based on the pioneering adenosine research of founder Michail Sitkovsky, Ph.D. The goal of Redox is to utilize A2 adenosine antagonists to re-activate the otherwise inhibited tumor-reactive T cells, which remain inhibited even after blockade of immunological checkpoint inhibitors. Redox has compiled key assets in this space, including an exclusive license to vipadenant, a potent and selective A2a adenosine receptor antagonist, and intellectual property covering the combination of adenosine antagonists with immuno-modulatory agents.

#SimilarOrganizations #More

REDOXTHERAPIES

Industry:
Health Care Pharmaceutical

Founded:
2006-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Status:
Active

Contact:
(617)742-3055


Similar Organizations

superlative-biosciences-logo

Superlative Biosciences

We provide superlative biosciences services.

unique-pharmaceuticals-logo

Unique Pharmaceuticals

Unique Pharmaceuticals provides sterile and non-sterile outsourcing services.

More informations about "RedoxTherapies"

RedoxTherapies - Crunchbase Company Profile & Funding

RedoxTherapies is a privately held company based on the pioneering adenosine research of founder Michail Sitkovsky, Ph.D. The goal of Redox is to utilize A2 adenosine antagonists to re-activate the otherwise inhibited tumor-reactive T cells, which remain inhibited even after โ€ฆSee details»

RedoxTherapies 2025 Company Profile: Valuation, Investors

RedoxTherapies General Information Description. Manufacturer of cancer treatment drugs. The company develops Vipadenant which is an adenosine receptor antagonist for cancer treatment.See details»

RedoxTherapies - Ownership and Business Overview - Mergr

Jul 14, 2016 RedoxTherapies, Inc. is an adenosine research company. Redox is to utilize A2 adenosine antagonists to re-activate the otherwise inhibited tumor-reactive T cells, which โ€ฆSee details»

Redoxtherapies, Inc. Company Profile | Boston, MA | Competitors ...

Find company research, competitor information, contact details & financial data for Redoxtherapies, Inc. of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»

RedoxTherapies - Products, Competitors, Financials, Employees ...

RedoxTherapies is a company based on the pioneering adenosine research of founder Michail Sitkovsky, Ph.D. The goal of Redox is to utilize A2 adenosine antagonists to re-activate the โ€ฆSee details»

The $10 million molecule: Juno Therapeuticsโ€™ โ€ฆ

Jul 15, 2016 Juno paid the $10 million for RedoxTherapies in cash, upfront, with the promise of additional payments when researchers pass undisclosed milestones. Juno announced the acquisition as it resumed ...See details»

Juno Therapeutics Adds Adenosine Receptor Antagonist Through ...

Jul 14, 2016 About Redox Therapies. RedoxTherapies is a privately held company based on the pioneering adenosine research of founder Michail Sitkovsky, Ph.D. The goal of Redox is to โ€ฆSee details»

Juno Therapeutics acquires RedoxTherapies - 2016-07-14

Acquired Organization: RedoxTherapies RedoxTherapies provides pioneering adenosine research. Acquiring Organization: Juno Therapeutics Juno Therapeutics is a clinical-stage โ€ฆSee details»

RedoxTherapies Acquired by Juno Therapeutics for $10M+

Jul 19, 2016 RedoxTherapies is a privately held company based on the pioneering adenosine research of founder Michail Sitkovsky, Ph.D. The goal of Redox is to utilize A2 adenosine โ€ฆSee details»

RedoxTherapies, Inc. - Drug pipelines, Patents, Clinical trials

Explore RedoxTherapies, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»

Redox therapy - Wikipedia

Redox therapy is an experimental therapy [1] [2] that aims to effect an outcome by modifying the levels of pro-oxidant and antioxidant agents in cells. [3] The term "redox" is a contraction of โ€ฆSee details»

Redox regulation: mechanisms, biology and therapeutic targets in ...

Mar 7, 2025 Redox signaling acts as a critical mediator in the dynamic interactions between organisms and their external environment, profoundly influencing both the onset and โ€ฆSee details»

Redox regulation in regenerative medicine and tissue engineering: โ€ฆ

One of the biggest challenges in tissue engineering and regenerative medicine is to incorporate a functioning vasculature to overcome the consequences of a lack of oxygen and nutrients in the โ€ฆSee details»

Potential of redox therapies in neurodegenerative disorders

Mar 1, 2017 Potential of redox therapies in neurodegenerative disorders Front Biosci (Elite Ed). 2017 Mar 1;9(2) :214-234. ... The World Health Organization (WHO) estimates that, by 2040, โ€ฆSee details»

Fundamentals of redox regulation in biology

Apr 30, 2024 A set of fundamental principles of organization of biological redox reactions in living cells and organisms, termed redox code, was formulated in 2015 (ref. 22).Here, the four โ€ฆSee details»

Perspectives in ROS/Redox Regulation Cancer Therapy

Dec 14, 2023 Each tumor (or cancer) is unique in terms of its growth, invasion, metastasis, and redox regulation. Tumor stroma, named as the tumor microenvironment (TME), also plays an โ€ฆSee details»

Redox regulation and its emerging roles in cancer treatment

Jan 15, 2023 Insights into how excessive ROS induce cell death will help guide the future of developing techniques to trigger a therapeutic dose of ROS against cancers [25].The effect of โ€ฆSee details»

New Emerging Therapeutic Strategies Based on Manipulation of โ€ฆ

Nov 6, 2024 Background: Resistance to standard therapeutic methods, including chemotherapy, immunotherapy, and targeted therapy, remains a critical challenge in effective cancer โ€ฆSee details»

Redox organization of living systems - ScienceDirect

May 1, 2024 Redox organization governs an underlying simplicity in living systems. Critically, redox reactions enable the essential characteristics of life: extraction of energy from the โ€ฆSee details»

Potential of redox therapies in neurodegenerative disorders

Recently significant advances have been made to understand the pathophysiological mechanisms of neurodegenerative disorders to provide real therapeutic benefits. There is evidence that โ€ฆSee details»

linkstock.net © 2022. All rights reserved